Is it geopolitically prudent for a large part of the US industrial supply chain to be inside of China? Why are American companies allowed to transfer critical technologies to China in exchange for short-term market access?
American firms are moving their R&D operations to China not just to take advantage of lower costs, but to be in close proximity to their supply chains. About 50 percent of foreign R&D centers in China are now run by American companies, helping China achieve first place in market share for manufacturing R&D.
American policy toward China is seeking to prevent American businesses from speeding the rise of an adversary. Tariffs are one piece of an emerging anti-China strategy. The Trump administration is rolling out new export controls to limit the transfer of sensitive technologies such as AI and quantum computing. They have blacklisted high-tech Chinese firms such as the telecom giant Huawei from doing business in the U.S.
China is working to reduce its dependence on foreign wide-body airplanes, semiconductors and oil and gas.
There will be decoupling on both sides. If the Trade War is resolved then it will be partial decoupling and diversification of supply chains rather than complete separation.
SOURCES- National Review, 2015 Global Innovation 1000’ by Strategy& and PwC
Written By Brian Wang, Nextbigfuture.com
nextbigfuture.com, the top online science blog. He is also involved in angel investing and raising funds for breakthrough technology startup companies.
He gave the recent keynote presentation at Monte Jade event with a talk entitled the Future for You. He gave an annual update on molecular nanotechnology at Singularity University on nanotechnology, gave a TEDX talk on energy, and advises USC ASTE 527 (advanced space projects program). He has been interviewed for radio, professional organizations. podcasts and corporate events. He was recently interviewed by the radio program Steel on Steel on satellites and high altitude balloons that will track all movement in many parts of the USA.
He fundraises for various high impact technology companies and has worked in computer technology, insurance, healthcare and with corporate finance.
He has substantial familiarity with a broad range of breakthrough technologies like age reversal and antiaging, quantum computers, artificial intelligence, ocean tech, agtech, nuclear fission, advanced nuclear fission, space propulsion, satellites, imaging, molecular nanotechnology, biotechnology, medicine, blockchain, crypto and many other areas.